Nicolas Demogeot

Vandoeuvre-les-nancy, 54519, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

SPINAL: study protocol for a multicenter non-inferiority trial evaluating reduce vertebral irradiation volumes in palliative radiotherapy for spinal bone metastases on analgesic efficacy.

SPINAL: study protocol for a multicenter non-inferiority trial evaluating reduce vertebral irradiation volumes in palliative radiotherapy for spinal bone metastases on analgesic efficacy.

Journal: BMC cancer

Published: January 23, 2026

In Reply to May et al.

In Reply to May et al.

Journal: International journal of radiation oncology, biology, physics

Published: November 04, 2025

Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.

Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: October 13, 2025

Reply to Federico Iori, Emanuele Alì, and Cinzia Iotti's Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. 88;2025:88:510-518.

Reply to Federico Iori, Emanuele Alì, and Cinzia Iotti's Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. 88;2025:88:510-518.

Journal: European urology

Published: September 24, 2025

Reply to Mattia Longoni, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. 88;2025:510-518.

Reply to Mattia Longoni, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. 88;2025:510-518.

Journal: European urology

Published: September 24, 2025

Oncological Outcomes and Organ Preservation After Brachytherapy for Penile Carcinoma: A Multicentric Retrospective Study by the Brachytherapy Group of the French Society for Radiation Oncology.

Oncological Outcomes and Organ Preservation After Brachytherapy for Penile Carcinoma: A Multicentric Retrospective Study by the Brachytherapy Group of the French Society for Radiation Oncology.

Journal: International journal of radiation oncology, biology, physics

Published: March 06, 2025

Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial.

Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial.

Journal: European urology

Published: February 20, 2025

Correction: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

Correction: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

Journal: Radiation oncology (London, England)

Published: January 23, 2025

Transition from pulsed dose rate to high dose rate brachytherapy: Experience of a single centre.

Transition from pulsed dose rate to high dose rate brachytherapy: Experience of a single centre.

Journal: Brachytherapy

Published: November 25, 2024

Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective study.

Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective study.

Journal: Radiation oncology (London, England)

Published: November 06, 2024

Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

Journal: Radiation oncology (London, England)

Published: June 19, 2024

Pattern of recurrence after fractionated stereotactic reirradiation in adult glioblastoma.

Pattern of recurrence after fractionated stereotactic reirradiation in adult glioblastoma.

Journal: Radiation oncology (London, England)

Published: June 02, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026